van DiepenA.T., TomlinsonG.A., JassalS.V.The association between exit-site infection and subsequent peritonitis among peritoneal dialysis patients.Clin J Am Soc Nephrol2012; 7: 1266–71.
2.
van DiepenA.T., JassalS.V.A qualitative systematic review of the literature supporting a causal relationship between exit-site infection and subsequent peritonitis in patients with end-stage renal disease treated with peritoneal dialysis.Perit Dial Int2013; 33: 604–10.
3.
LloydA., TangriN., ShaferL.A., RigattoC., PerlJ., KomendaP.The risk of peritonitis after an exit site infection: a time-matched, case-control study.Nephrol Dial Transplant2013; 28: 1915–21.
4.
KeaneW.F., EverettE.D., GolperT.A., GokalR., HalstensonC., KawaguchiY.Peritoneal dialysis-related peritonitis treatment recommendations. 1993 update. The Ad Hoc Advisory Committee on Peritonitis Management. International Society for Peritoneal Dialysis.Perit Dial Int1993; 13: 14–28.
PirainoB., BernardiniJ., BrownE., FigueiredoA., JohnsonD.W., LyeW.C.ISPD Position statement on reducing the risks of peritoneal dialysis-related infections.Perit Dial Int2011; 31: 614–30.
10.
AtkinsD., BestD., BrissP.A., EcclesM., Falck-YtterY., FlottorpS.; GRADE Working Group. Grading quality of evidence and strength of recommendations.BMJ2004; 328: 1490.
11.
WaradyB.A., BakkalogluS., NewlandJ., CantwellM., VerrinaE., NeuA.Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.Perit Dial Int2012; 32(Suppl 2): S32–86.
12.
AbrahamG., SavinE., AyiomamitisA., IzattS., VasS.I., MatthewsR.E.Natural history of exit-site infection (ESI) in patients on continuous ambulatory peritoneal dialysis (CAPD).Perit Dial Bull1988; 8: 211–6.
GonthierD., BernardiniJ., HolleyJ.L., PirainoB.Erythema: does it indicate infection in a peritoneal catheter exit site?Adv Perit Dial1992; 8: 230–3.
15.
PlumJ., SudkampS., GrabenseeB.Results of ultrasound-assisted diagnosis of tunnel infections in continuous ambulatory peritoneal dialysis.Am J Kidney Dis1994; 23: 99–104.
16.
HolleyJ.L., BernardiniJ., PirainoB.Risk factors for tunnel infections in continuous peritoneal dialysis.Am J Kidney Dis1991; 18: 344–8.
17.
BorgD., ShettyA., WilliamsD., FaberM.D.Fivefold reduction in peritonitis using a multifaceted continuous quality initiative program.Adv Perit Dial2003; 19: 202–5.
18.
Diaz-BuxoJ.A., WickG.S., PesichA.A.Using CQI techniques for managing infections in PD patients.Nephrol News Issues1998; 12: 22–4.
19.
SchaeferF., KandertM., FenebergR.Methodological issues in assessing the incidence of peritoneal dialysis-associated peritonitis in children.Perit Dial Int2002; 22: 234–8.
20.
PirainoB.Today's approaches to prevent peritonitis.Contrib Nephrol2012; 178: 246–50.
21.
FigueiredoA., GohB., JenkinsS., JohnsonD.W., MactierR., RamalakshmiS.Clinical practice guidelines for peritoneal access.Perit Dial Int2010; 30: 424–9.
22.
StrippoliG.F., TongA., JohnsonD., SchenaF.P., CraigJ.C.Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials.Am J Kidney Dis2004; 44: 591–603.
23.
WikdahlA.M., EngmanU., StegmayrB.G., SorenssenJ.G.One-dose cefuroxime i.v. and i.p. reduces microbial growth in PD patients after catheter insertion.Nephrol Dial Transplant1997; 12: 157–60.
24.
LyeW.C., LeeE.J., TanC.C.Prophylactic antibiotics in the insertion of Tenckhoff catheters.Scand J Urol Nephrol1992; 26: 177–80.
25.
Bennet-JonesD.N., MartinJ.B., BarrattA.J., DuffyT.J., NaishP.F., AberG.M.Prophylactic gentamicin in the prevention of early exit-site infections and peritonitis in CAPD.Adv Perit Dial1988; 4: 147–50.
26.
GadallahM.F., RamdeenG., MignoneJ., PatelD., MitchellL., TatroS.Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters.Am J Kidney Dis2000; 36: 1014–9.
27.
RestrepoC.A., BuitragoC.A., HolguinC.Implantation of peritoneal catheters by laparotomy: nephrologists obtained similar results to general surgeons.Int J Nephrol Renovasc Dis2014; 7: 383–90.
28.
de MoraesT.P., CamposR.P., de AlcântaraM.T., ChulaD., VieiraM.A., RiellaM.C.Similar outcomes of catheters implanted by nephrologists and surgeons: analysis of the Brazilian peritoneal dialysis multicentric study.Semin Dial2012; 25: 565–8.
29.
CoxT.C., BlairL.J., HuntingtonC.R., PrasadT., KercherK.W., HenifordB.T.Laparoscopic versus open peritoneal dialysis catheter placement.Surg Endosc2016; 30: 899–905.
30.
XieH., ZhangW., ChengJ., HeQ.Laparoscopic versus open catheter placement in peritoneal dialysis patients: a systematic review and meta-analysis.BMC Nephrol2012; 13: 69.
31.
ChulaD.C., CamposR.P., de AlcântaraM.T., RiellaM.C., do NascimentoM.M.Percutaneous and surgical insertion of peritoneal catheter in patients starting in chronic dialysis therapy: a comparative study.Semin Dial2014; 27: E32–7.
32.
Al-HwieshA.K.Percutaneous versus laparoscopic placement of peritoneal dialysis catheters: simplicity and favorable outcome.Saudi J Kidney Dis Transpl2014; 25: 1194–201.
33.
SunC., ZhangM., JiangC.Vertical tunnel-based low-site peritoneal dialysis catheter implantation decreases the incidence of catheter malfunction.Am Surg2015; 81: 1157–62.
34.
StrippoliG.F., TongA., JohnsonD., SchenaF.P., CraigJ.C.Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials.J Am Soc Nephrol2004; 15: 2735–46.
35.
EjlersenE., StevenK., LokkegaardH.Paramedian versus midline incision for the insertion of permanent peritoneal dialysis catheters. A randomized clinical trial.Scand J Urol Nephrol1990; 24: 151–4.
36.
RubinJ., DidlakeR., RajuS., HsuH.A prospective randomized evaluation of chronic peritoneal catheters. Insertion site and intraperitoneal segment.ASAIO Trans1990; 36: M497–500.
37.
CrabtreeJ.H.Selected best demonstrated practices in peritoneal dialysis access.Kidney Int Suppl2006; 103: S27–37.
38.
DombrosN., DratwaM., FerianiM., GokalR., HeimbürgerO., KredietR.European best practice guidelines for peritoneal dialysis. 3 Peritoneal access.Nephrol Dial Transplant2005; 20(Suppl 9): ix8–12.
39.
BrumS., RodriguesA., RochaS., CarvalhoM.J., NogueiraC., MagalhãesC.Moncrief-Popovich technique is an advantageous method of peritoneal dialysis catheter implantation.Nephrol Dial Transplant2010; 25: 3070–5.
40.
ParkM.S., YimA.S., ChungS.H., LeeE.Y., ChaM.K., KimJ.H.Effect of prolonged subcutaneous implantation of peritoneal catheter on peritonitis rate during CAPD: a prospective randomized study.Blood Purif1998; 16: 171–8.
41.
DanielssonA., BlohmeL., TranaeusA., HylanderB.A prospective randomized study of the effect of a subcutaneously ‘buried’ peritoneal dialysis catheter technique versus standard technique on the incidence of peritonitis and exit-site infection.Perit Dial Int2002; 22: 211–9.
42.
LiuY., ZhangL., LinA., NiZ., QianJ., FangW.Impact of break-in period on the short-term outcomes of patients started on peritoneal dialysis.Perit Dial Int2014; 34: 49–56.
43.
PovlsenJ.V., IvarsenP.How to start the late referred ESRD patient urgently on chronic APD.Nephrol Dial Transplant2006; 21(Suppl 2): ii56–9.
44.
SharmaA.P., MandhaniA., DanielS.P., FillerG.Shorter break-in period is a viable option with tighter PD catheter securing during the insertion.Nephrology (Carlton)2008; 13: 672–6.
45.
YangY.F., WangH.J., YehC.C., LinH.H., HuangC.C.Early initiation of continuous ambulatory peritoneal dialysis in patients undergoing surgical implantation of Tenckhoff catheters.Perit Dial Int2011; 31: 551–7.
46.
RanganathanD., BaerR., FassettR.G., WilliamsN., HanT., WatsonM., HealyH.Randomised controlled trial to determine the appropriate time to initiate peritoneal dialysis after insertion of catheter to minimise complications (Timely PD study).BMC Nephrol2010; 11: 11.
47.
AkyolA.M., PorteousC., BrownM.W.A comparison of two types of catheters for continuous ambulatory peritoneal dialysis (CAPD).Perit Dial Int1990; 10: 63–6.
48.
EklundB.H., HonkanenE.O., KalaA.R., KyllonenL.E.Catheter configuration and outcome in patients on continuous ambulatory peritoneal dialysis: a prospective comparison of two catheters.Perit Dial Int1994; 14: 70–4.
49.
EklundB.H., HonkanenE.O., KalaA.R., KyllonenL.E.Peritoneal dialysis access: prospective randomized comparison of the swan neck and Tenckhoff catheters.Perit Dial Int1995; 15: 353–6.
50.
LyeW.C., KourN.W., van der StraatenJ.C., LeongS.O., LeeE.J.A prospective randomized comparison of the swan neck, coiled, and straight Tenckhoff catheters in patients on CAPD.Perit Dial Int1996; 16(Suppl 1): S333–5.
51.
NielsenP.K., HemmingsenC., FriisS.U., LadefogedJ., OlgaardK.Comparison of straight and curled Tenckhoff peritoneal dialysis catheters implanted by percutaneous technique: a prospective randomized study.Perit Dial Int1995; 15: 18–21.
JohnsonD.W., WongJ., WigginsK.J., KirwanR., GriffinA., PrestonJ.A randomized controlled trial of coiled versus straight swan-neck Tenckhoff catheters in peritoneal dialysis patients.Am J Kidney Dis2006; 48: 812–21.
54.
HagenS.M., LafrancaJ.A., IjzermansJ.N., DorF.J.A systematic review and meta-analysis of the influence of peritoneal dialysis catheter type on complication rate and catheter survival.Kidney Int2014; 85: 920–32.
55.
XieJ.Y., ChenN., RenH., HuangX.M., ZhuP.Prospective studies on applications of a two-cuff swan neck catheter and a Tenckhoff catheter to Chinese CAPD patients.Clin Nephrol2009; 72: 373–9.
56.
LiC.L., CuiT.G., GanH.B., CheungK., LioW.I., KuokU.I.A randomized trial comparing conventional swan-neck straight-tip catheters to straight-tip catheters with an artificial subcutaneous swan neck.Perit Dial Int2009; 29: 278–84.
NessimS.J., BargmanJ.M., JassalS.V.Relationship between double-cuff versus single-cuff peritoneal dialysis catheters and risk of peritonitis.Nephrol Dial Transplant2010; 25: 2310–4.
LoW.K., LuiS.L., LiF.K., ChoyB.Y., LamM.F., TseK.C.A prospective randomized study on three different peritoneal dialysis catheters.Perit Dial Int2003; 23(Suppl 2): S127–31.
62.
CrabtreeJ.H., BurchetteR.J.Comparative analysis of two-piece extended peritoneal dialysis catheters with remote exit-site locations and conventional abdominal catheters.Perit Dial Int2010; 30: 46–55.
63.
CrabtreeJ.H., BurchetteR.J., SiddiqiR.A., HuenI.T., HadnottL.L., FishmanA.The efficacy of silver-ion implanted catheters in reducing peritoneal dialysis-related infections.Perit Dial Int2003; 23: 368–74.
64.
TobinE.J., BambauerR.Silver coating of dialysis catheters to reduce bacterial colonization and infection.Ther Apher Dial2003; 7: 504–9.
65.
KimC.Y., KumarA., SampathL., SokolK., ModakS.Evaluation of an antimicrobial-impregnated continuous ambulatory peritoneal dialysis catheter for infection control in rats.Am J Kidney Dis2002; 39: 165–73.
66.
MaiorcaR., CantaluppiA., CancariniG.C., ScalamognaA., BroccoliR., GrazianiG.Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis.Lancet1983; 2: 642–4.
67.
ChengI.K., ChanC.Y., ChengS.W., PoonJ.F., JiY.L., LoW.K.A randomized prospective study of the cost-effectiveness of the conventional spike, O-set, and UVXD techniques in continuous ambulatory peritoneal dialysis.Perit Dial Int1994; 14: 255–60.
68.
CanadianC.A.P.D. Clinical Trials Group. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems.Perit Dial Int1989; 9: 159–63.
69.
LiP.K., ChanT.H., SoW.Y., WangA.Y., LeungC.B., LaiK.N.Comparisons of Y-set disconnect system (Ultraset) versus conventional spike system in uremic patients on CAPD: outcome and cost analysis.Perit Dial Int1996; 16(Suppl 1): S368–70.
70.
OwenJ.E., WalkerR.G., LemonJ., BrettL., MitrouD., BeckerG.J.Randomized study of peritonitis with conventional versus O-set techniques in continuous ambulatory peritoneal dialysis.Perit Dial Int1992; 12: 216–20.
71.
HarrisD.C., YuillE.J., BythK., ChapmanJ.R., HuntC.Twin- versus single-bag disconnect systems: infection rates and cost of continuous ambulatory peritoneal dialysis.J Am Soc Nephrol1996; 7: 2392–8.
72.
KiernanL., KligerA., Gorban-BrennanN., JuergensenP., TesinD., VoneshE.Comparison of continuous ambulatory peritoneal dialysis-related infections with different ‘Y-tubing’ exchange systems.J Am Soc Nephrol1995; 5: 1835–8.
73.
LiP.K., SzetoC.C., ChauK.F., FungK.S., LeungC.B., LiC.S.Comparison of double-bag and Y-set disconnect systems in continuous ambulatory peritoneal dialysis: a randomized prospective multicenter study.Am J Kidney Dis1999; 33: 535–40.
74.
FigueiredoA.E., BernardiniJ., BowesE., HiramatsuM., PriceV., SuC.ISPD guideline/recommendations: a syllabus for teaching peritoneal dialysis to patients and caregivers.Perit Dial Int2016; 36(6): 592–605.
ZhangL., HawleyC.M., JohnsonD.W.Focus on peritoneal dialysis training: working to decrease peritonitis rates.Nephrol Dial Transplant2016; 31: 214–22.
77.
YangZ., XuR., ZhuoM., DongJ.Advanced nursing experience is beneficial for lowering the peritonitis rate in patients on peritoneal dialysis.Perit Dial Int2012; 32: 60–6.
78.
ChowK.M., SzetoC.C., LawM.C., FungJ., LiP.K.Influence of peritoneal dialysis training nurses’ experience on peritonitis rates.Clin J Am Soc Nephrol2007; 2: 647–52.
79.
BenderF.H., BernardiniJ., PirainoB.Prevention of infectious complications in peritoneal dialysis: best demonstrated practices.Kidney Int Suppl2006; 103: S44–54.
80.
WongL.P., YamamotoK.T., ReddyV., CobbD., ChamberlinA., PhamH.Patient education and care for peritoneal dialysis catheter placement: a quality improvement study.Perit Dial Int2014; 34: 12–23.
SayedS.A., Abu-AishaH., AhmedM.E., ElaminS.Effect of the patient's knowledge on peritonitis rates in peritoneal dialysis.Perit Dial Int2013; 33: 362–6.
84.
BaroneR.J., CamporaM.I., GimenezN.S., RamirezL., SantopietroM., PaneseS.A.The importance of the Patient's training in chronic peritoneal dialysis and peritonitis.Adv Perit Dial2011; 27: 97–100.
85.
FigueiredoA.E., MoraesT.P., BernardiniJ., Poli-de-FigueiredoC.E., BarrettiP., OlandoskiM. BRAZPD Investigators. Impact of patient training patterns on peritonitis rates in a large national cohort study.Nephrol Dial Transplant2015; 30: 137–42.
FarinaJ.Peritoneal dialysis: a case for home visits.Nephrol Nurs J2001; 28: 423–8.
89.
MartinoF., AdιbelliZ., MasonG., NayakA., AriyanonW., RettoreEHome visit program improves technique survival in peritoneal dialysis.Blood Purif2014; 37: 286–90.
90.
RussoR., ManiliL., TiraboschiG., AmarK., De LucaM., AlberghiniE.Patient re-training in peritoneal dialysis: why and when it is needed.Kidney Int Suppl2006; 103: S127–32.
91.
ArndtJ.The role of memory activation in creating false memories of encoding context.J Exp Psychol Learn Mem Cogn2010; 36: 66–79.
92.
BordinG., CassatiM., SicoloN., ZuccheratoN., EduatiV.Patient education in peritoneal dialysis: an observational study in Italy.J Ren Care2007; 33: 165–71.
93.
LuzarM.A., BrownC.B., BalfD., HillL., IssadB., MonnierB.Exit-site care and exit-site infection in continuous ambulatory peritoneal dialysis (CAPD): results of a randomized multicenter trial.Perit Dial Int1990; 10: 25–9.
94.
WaiteN.M., WebsterN., LaurelM., JohnsonM., FongI.W.The efficacy of exit site povidone-iodine ointment in the prevention of early peritoneal dialysis-related infections.Am J Kidney Dis1997; 29: 763–8.
95.
WilsonA.P., LewisC., O'SullivanH., ShettyN., NeildG.H., MansellM.The use of povidone iodine in exit-site care for patients undergoing continuous peritoneal dialysis (CAPD).J Hosp Infect1997; 35: 287–93.
96.
MushaharL., MeiL.W., YusufW.S., SivathasanS., KamaruddinN., IdzhamN.J.Exit-site dressing and infection in peritoneal dialysis: a randomized controlled pilot trial.Perit Dial Int2016; 36: 135–9.
97.
WangJ.L., HungS.Y., ChangM.Y., WuY.H., WangH.H.Daily chlorhexidine care at exit site in patients with peritoneal dialysis: a randomized control trial.J Microbiol Imm Inf2015; 48(Suppl 1): S57–8.
98.
Mendoza-GuevaraL., Castro-VazquezF., Aguilar-KitsuA., Morales-NavaA., Rodriguez-LeyvaF., Sanchez-BarbosaJ.L.Amuchina 10% solution, safe antiseptic for preventing infections of exit-site of Tenckhoff catheters, in the pediatric population of a dialysis program.Contrib Nephrol2007; 154: 139–44.
99.
GrosmanM.D., MosqueraV.M., HernandezM.G., AgostiniS., AdragnaM., SojoE.T.3% Amuchina is as effective as the 50% concentration in the prevention of exit-site infection in children on chronic peritoneal dialysis.Adv Perit Dial2005; 21: 148–50.
100.
WadhwaN.K., SuhH., CabraldaT., StratosJ., CascioC., IrwinC.A randomized trial of Amuchina 10% versus povidone-iodine 10% solution for exit-site care/infection in peritoneal dialysis patients.Perit Dial Int1995; 15: S1–64.
101.
WadhwaN.K., SuhH., CabraldaT.Amuchina 5% versus povidone-iodine 10% solution for exit-site care/infection in peritoneal dialysis patients.Perit Dial Int1997; 17: S1–46.
102.
ChuaA.N., GoldsteinS.L., BellD., BrewerE.D.Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in children.Clin J Am Soc Nephrol2009; 4: 1939–43.
103.
FuchsJ., GallagherE., Jackson-BeyD., KrawtzD., SchreiberM.J.A prospective randomized study of peritoneal catheter exit-site care.Nephrol Hypertens1990; 19: 81–4.
104.
JonesL.L., TweedyL., WaradyB.A.The impact of exit-site care and catheter design on the incidence of catheter-related infections.Adv Perit Dial1995; 11: 302–5.
105.
SheltonD.M.A comparison of the effects of two antiseptic agents on Staphylococcus epidermidis colony forming units at the peritoneal dialysis catheter exit site.Adv Perit Dial1991; 7: 120–4.
106.
TacconelliE., CarmeliY., AizerA., FerreiraG., ForemanM.G., D'AgataE.M.Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis.Clin Infect Dis2003; 37: 1629–38.
107.
BernardiniJ., PirainoB., HolleyJ., JohnstonJ.R., LutesR.A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.Am J Kidney Dis1996; 27: 695–700.
108.
ChuK.H., ChoyW.Y., CheungC.C., FungK.S., TangH.L., LeeW.A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections.Perit Dial Int2008; 28: 505–8.
109.
XuG., TuW., XuC.Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis.Nephrol Dial Transplant2010; 25: 587–92.
110.
MahajanS., TiwariS.C., KalraV., BhowmikD.M., AgarwalS.K., DashS.C.Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population.Perit Dial Int2005; 25: 473–7.
111.
LimC.T., WongK.S., FooM.W.The impact of topical mupirocin on peritoneal dialysis infection in Singapore General Hospital.Nephrol Dial Transplant2005; 20: 2202–6.
112.
DavenportA.Do topical antibiotics reduce exit-site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit.J Nephrol2012; 25: 819–24.
113.
WongC., LukI.W., IpM., YouJ.H.Prevention of gram-positive infections in peritoneal dialysis patients in Hong Kong: a cost-effectiveness analysis.Am J Infect Control2014; 42: 412–6.
114.
AykutS., CanerC., OzkanG., AliC., TugbaA., ZeynepG.Mupirocin application at the exit site in peritoneal dialysis patients: five years of experience.Ren Fail2010; 32: 356–61.
115.
LobbedeezT., GardamM., DedierH., BurdzyD., ChuM., IzattS.Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years.Nephrol Dial Tranplant2004; 19: 3140–3.
116.
Perez-FontanM., RosalesM., Rodriguez-CarmonaA., FalconT.G., ValdesF.Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis.Am J Kidney Dis2002; 39: 337–41.
117.
AnnigeriR., ConlyJ., VasS., DedierH., PrakashanK.P., BargmanJ.M.Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection.Perit Dial Int2001; 21: 554–9.
118.
Al-HwieshA.K., Abdul-RahmanI.S., Al-MuhannaF.A., Al-SulaimanM.H., Al-JondebiM.S., Divino-FilhoJ.C.Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.Int J Artif Organs2013; 36: 473–83.
119.
PirainoB.Mupirocin for preventing peritonitis and exit site infections in patients undergoing peritoneal dialysis. Was it effective?Nephrol Dial Transplant2010; 25: 349–52.
120.
RiuS., RuizC.G., Martinez-VeaA., PeraltaC., OliverJ.A.Spontaneous rupture of polyurethane peritoneal catheter. A possible deleterious effect of mupirocin ointment.Nephrol Dial Transplant1998; 13: 1870–1.
121.
MontenegroJ., SarachoR., AguirreR., MartinezI., IribarI., OcharanJ.Exit-site care with ciprofloxacin otologic solution prevents polyurethane catheter infection in peritoneal dialysis patients.Perit Dial Int2000; 20: 209–14.
122.
PirainoB., BernardiniJ., FlorioT., FriedL.Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients.Perit Dial Int2003; 23: 456–9.
123.
MahaldarA., WeiszM., KathuriaP.Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.Adv Perit Dial2009; 25: 56–9.
124.
PierceD.A., WilliamsonJ.C., MauckV.S., RussellG.B., PalavecinoE., BurkartJ.M.The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis.Perit Dial Int2012; 32: 525–30.
125.
LoM.W., MakS.K., WongY.Y., LoK.C., ChanS.F., TongG.M.Atypical mycobacterial exit-site infection and peritonitis in peritoneal dialysis patients on prophylactic exit-site gentamicin cream.Perit Dial Int2013; 33: 267–72.
126.
WongP.N., TongG.M., WongY.Y., LoK.Y., ChanS.F., LoM.W.Alternating mupirocin/gentamicin is associated with increased risk of fungal peritonitis as compared with gentamicin alone—results of a randomized open-label controlled trial.Perit Dial Int2016; 36(3): 340–6.
127.
ChenS.S., ShethH., PirainoB., BenderF.Long-term exit-site gentamicin prophylaxis and gentamicin resistance in a peritoneal dialysis program.Perit Dial Int2016; 36(4): 387–9.
128.
JohnsonD.W., BadveS.V., PascoeE.M., BellerE., CassA., ClarkC.Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial.Lancet Infect Dis2014; 14: 23–30.
129.
McQuillanR.F., ChiuE., NessimS., LokC.E., RoscoeJ.M., TamP.A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study.Clin J Am Soc Nephrol2012; 7: 297–303.
130.
ThokhonelidzeI., MaglakelidzeN., SarishviliN., KasradzeT., DalakishviliK.Single-center experience in successful prevention of exit-site infection in patients on peritoneal dialysis.Georgian Med News2015; 241: 54–8.
131.
Núñez-MoralM., Sánchez-álvarezE., González-DíazI., Peláez-RequejoB., Fernández-ViñaA., Quintana-FernándezA.Exit-site infection of peritoneal catheter is reduced by the use of polyhexanide. Results of a prospective randomized trial.Perit Dial Int2014; 34: 271–7.
132.
FindlayA., SerranoC., PunzalanS., FanS.L.Increased peritoneal dialysis exit site infections using topical antiseptic polyhexamethylene biguanide compared to mupirocin: results of a safety interim analysis of an open-label prospective randomized study.Antimicrob Agents Chemother2013; 57: 2026–8.
133.
TamB.M., ChowS.K.A preliminary report on the effectiveness of nanotechnology anti-microbial spray dressing in preventing Tenckhoff catheter exit-site infection.Perit Dial Int2014; 34: 670–3.
134.
FiranekC., GuestS.Hand hygiene in peritoneal dialysis.Perit Dial Int2011; 31: 399–408.
135.
ProwantB.F., WaradyB.A., NolphK.D.Peritoneal dialysis catheter exit-site care: results of an international survey.Perit Dial Int1993; 13: 149–54.
136.
MooreC.G.Comparison of Blisterfilm and gauze for peritoneal catheter exit-site care.ANNA J1989; 16: 475–8.
137.
CocksedgeB., HuntD., WesterholmW., HeathcoteK., PollockC.Peritoneal catheter exit-site care for the maintenance CAPD patient: report of a randomised, prospective study.Renal Educator1993; 13: 4–6.
138.
SIPROCE Study Group.Efficiency of a silver ring in preventing exit-site infections in adult PD patients: results of the SIPROCE Study. Silver ring prophylaxis of the catheter exit site.Adv Perit Dial1997; 13: 227–32.
139.
TimsitJ.F., SchwebelC., BouadmaL., GeffroyA., Garrouste-OrgeasM., PeaseS.; Dressing Study Group. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial.JAMA2009; 301: 1231–41.
140.
ScalamognaA., CastelnovoC., De VecchiA., PonticelliC.Exit-site and tunnel infections in continuous ambulatory peritoneal dialysis patients.Am J Kidney Dis1991; 18: 674–7.
141.
Pérez-FontánM., RosalesM., Rodríguez-CarmonaA., MoncaliánJ., Fernández-RiveraC., CaoM.Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin.Adv Perit Dial1992; 8: 242–5.
142.
Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group.J Am Soc Nephrol1996; 7: 2403–8.
143.
SessoR., ParisioK., DalboniA., RabeloT., BarbosaD., CendorogloM.Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.Clin Nephrol1994; 41: 370–6.
144.
ZimmermanS.W., AhrensE., JohnsonC.A., CraigW., LeggettJ., O'BrienM.Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections.Am J Kidney Dis1991; 18: 225–31.
145.
BloweyD.L., WaradyB.A., McFarlandK.S.The treatment of Staphylococcus aureus nasal carriage in pediatric peritoneal dialysis patients.Adv Perit Dial1994; 10: 297–9.
146.
FalagasM.E., FragoulisK.N., BliziotisI.A.Oral rifampin for prevention of S. aureus carriage-related infections in patients with renal failure—a meta-analysis of randomized controlled trials.Nephrol Dial Transplant2006; 21: 2536–42.
147.
ChurchillD.N., TaylorD.W., VasS.I.Peritonitis in continuous ambulatory peritoneal dialysis patients: a randomized clinical trial of cotrimoxazole prophylaxis.Perit Dial Int1988; 8: 125–8.
Poole-WarrenL.A., HallettM.D., HoneP.W., BurdenS.H., FarrellP.C.Vaccination for prevention of CAPD associated staphylococcal infection: results of a prospective multicentre clinical trial.Clin Nephrol1991; 35: 198–206.
150.
Rodríguez-CarmonaA., Pérez-FontánM., López-MuñizA., Ferreiro-HermidaT., García-FalcónT.Correlation between glycemic control and the incidence of peritoneal and catheter tunnel and exit-site infections in diabetic patients undergoing peritoneal dialysis.Perit Dial Int2014; 34: 618–26.
151.
HuangW.H., YenT.H., ChanM.J., SuY.J.Impact of environmental particulate matter and peritoneal dialysis-related infection in patients undergoing peritoneal dialysis.Medicine (Baltimore)2014; 93: e149.
152.
CampbellD.J., BrownF.G., CraigJ.C., GallagherM.P., JohnsonD.W., KirklandG.S.Assessment of current practice and barriers to antimicrobial prophylaxis in peritoneal dialysis patients.Nephrol Dial Transplant2015. pii: gfv115. [Epub ahead of print.]
153.
ChoY., JohnsonD.W.Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes.Am J Kidney Dis2014; 64: 278–89.
154.
WangJ., ZhangH., LiuJ., ZhangK., YiB., LiuY.Implementation of a continuous quality improvement program reduces the occurrence of peritonitis in PD.Ren Fail2014; 36: 1029–32.
155.
YuY., ZhouY., WangH., ZhouT., LiQ., LiT.Impact of continuous quality improvement initiatives on clinical outcomes in peritoneal dialysis.Perit Dial Int2014; 34(Suppl 2): S43–8.
156.
PirainoB., BernardiniJ., SorkinM.The influence of peritoneal catheter exit-site infections on peritonitis, tunnel infections, and catheter loss in patients on continuous ambulatory peritoneal dialysis.Am J Kidney Dis1986; 8: 436–40.
157.
PirainoB., BernardiniJ., SorkinM.Catheter infections as a factor in the transfer of continuous ambulatory peritoneal dialysis patients to hemodialysis.Am J Kidney Dis1989; 13: 365–9.
158.
GuptaB., BernardiniJ., PirainoB.Peritonitis associated with exit site and tunnel infections.Am J Kidney Dis1996; 28: 415–9.
BunkeM., BrierM.E., GolperT.A.Pseudomonas peritonitis in peritoneal dialysis patients: the Network #9 Peritonitis Study.Am J Kidney Dis1995; 25: 769–74.
162.
KazmiH.R., RaffoneF.D., KligerA.S., FinkelsteinF.O.Pseudomonas exit site infections in continuous ambulatory peritoneal dialysis patients.J Am Soc Nephrol1992; 2: 1498–1501.
163.
JuergensenP.H., FinkelsteinF.O., BrennanR., SantacroceS., AhernM.J.Pseudomonas peritonitis associated with continuous ambulatory peritoneal dialysis: a six-year study.Am J Kidney Dis1988; 11: 413–7.
164.
FillastreJ.P., LeroyA., MoulinB., DhibM., Borsa-LebasF., HumbertG.Pharmacokinetics of quinolones in renal insufficiency.J Antimicrob Chemother1990; 26(Suppl B): 51–60.
165.
HardyD.J., GuayD.R., JonesR.N.Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overview.Diagn Microbiol Infect Dis1992; 15: 39–53.
166.
American Thoracic Society/CDC/Infectious Diseases Society of America.Treatment of tuberculosis.MMWR Recomm Rep2003; 52(RR-11): 1–77.
167.
SchifflH., MuckeC., LangS.M.Exit-site infections by nondiphtheria Corynebacteria in CAPD.Perit Dial Int2004; 24: 454–9.
168.
KwanT.H., TongM.K., SiuY.P., LeungK.T., LukS.H., CheungY.K.Ultrasonography in the management of exit site infections in peritoneal dialysis patients.Nephrology (Carlton)2004; 9: 348–52.
169.
LuiS.L., LiF.K., LoC.Y., LoW.K.Simultaneous removal and reinsertion of Tenckhoff catheters for the treatment of refractory exit-site infection.Adv Perit Dial2000; 16: 195–7.
170.
PosthumaN., BorgsteinP.J., EijsboutsQ., ter WeeP.M.Simultaneous peritoneal dialysis catheter insertion and removal in catheter-related infections without interruption of peritoneal dialysis.Nephrol Dial Transplant1998; 13: 700–3.
171.
SwartzR., MessanaJ., ReynoldsJ., RanjitU.Simultaneous catheter replacement and removal in refractory peritoneal dialysis infections.Kidney Int1991; 40: 1160–5.
172.
VychytilA., LorenzM., SchneiderB., HorlW.H., Haag-WeberM.New criteria for management of catheter infections in peritoneal dialysis patients using ultrasonography.J Am Soc Nephrol1998; 9: 290–6.
173.
YoshinoA., HondaM., IkedaM., TsuchidaS., HatayaH., SakazumeS.Merit of the cuff-shaving procedure in children with chronic infection.Pediatr Nephrol2004; 19: 1267–72.
174.
LuiS.L., YipT., TseK.C., LamM.F., LaiK.N., LoW.K.Treatment of refractory Pseudomonas aeruginosa exit-site infection by simultaneous removal and reinsertion of peritoneal dialysis catheter.Perit Dial Int2005; 25: 560–3.
175.
SchaeferF., KlausG., Müller-WiefelD.E., MehlsO.Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis.J Am Soc Nephrol1999; 10: 136–45.
176.
KorzetsZ., ErdbergA., GolanE., Ben-ChitritS., VernerM., RathausV.Frequent involvement of the internal cuff segment in CAPD peritonitis and exit-site infection—an ultrasound study.Nephrol Dial Transplant1996; 11: 336–9.
177.
HolleyJ.L., FoulksC.J., MossA.H., WillardD.Ultrasound as a tool in the diagnosis and management of exit-site infections in patients undergoing continuous ambulatory peritoneal dialysis.Am J Kidney Dis1989; 14: 211–6.
178.
VychytilA., LilajT., LorenzM., HörlW.H., Haag-WeberM.Ultrasonography of the catheter tunnel in peritoneal dialysis patients: what are the indications?Am J Kidney Dis1999; 33: 722–7.
179.
LewS.Q., GruiaA.Ofloxacin solution for persistent exit-site and tunnel infection in peritoneal dialysis.Perit Dial Int2013; 33: 101–2.
180.
BurkhalterF., ClemengerM., HaddoubS.S., McGroryJ., HisoleN., BrownE.Pseudomonas exit-site infection: treatment outcomes with topical gentamicin in addition to systemic antibiotics.Clin Kidney J2015; 8: 781–4.
181.
WongF.S.Use of cleansing agents at the peritoneal catheter exit site.Perit Dial Int2003; 23(Suppl 2): S148–52.
182.
HumbertG., SpykerD.A., FillastreJ.P., LeroyA.Pharmacokinetics of amoxicillin: dosage nomogram for patients with impaired renal function.Antimicrob Agents Chemother1979; 15: 28–33.
183.
WilcoxM.H., EdwardsR., FinchR.G.Laboratory studies on coagulase-negative staphylococci from CAPD-associated peritonitis.J Antimicrob Chemother1985; 15: 297–303.
184.
TaegtmeyerM., SaxenaR., CorkillJ.E., AnijeetH., ParryC.M.Ciprofloxacin treatment of bacterial peritonitis associated with chronic ambulatory peritoneal dialysis caused by Neisseria cinerea.J Clin Microbiol2006; 44: 3040–1.
185.
PlumJ., ArtikS., BuschT., SahinK., GrabenseeB.Oral versus intraperitoneal application of clindamycin in tunnel infections: a prospective, randomized study in CAPD patients.Perit Dial Int1997; 17: 486–92.
186.
LintonA.L., LawsonD.H., MacvarishI., EakinJ.S.Antibiotic therapy in patients on regular dialysis treatment.EDTA Proceddings1968; 5: 153–7.
187.
MaT.K., ChowK.M., ChoyA.S., KwanB.C., SzetoC.C., LiP.K.Clinical manifestation of macrolide antibiotic toxicity in CKD and dialysis patients.Clin Kidney J2014; 7: 507–12.
188.
ChanT.M., ChanC.Y., ChengS.W., LoW.K., LoC.Y., ChengI.K.Treatment of fungal peritonitis complicating continuous ambulatory peritoneal dialysis with oral fluconazole: a series of 21 patients.Nephrol Dial Transplant1994; 9: 539–42.
189.
ChengI.K., FangG.X., ChauP.Y., ChanT.M., TongK.L., WongA.K.A randomized prospective comparison of oral levofloxacin plus intraperitoneal (IP) vancomycin and IP netromycin plus IP vancomycin as primary treatment of peritonitis complicating CAPD.Perit Dial Int1998; 18: 371–5.
190.
SongI.J., SeoJ.W., KwonY.E., KimY.L., LimT.S., KangE.W.Successful treatment of vancomycin-resistant enterococcus peritonitis using linezolid without catheter removal in a peritoneal dialysis patient.Perit Dial Int2014; 34: 235–9.
191.
WuV.C., WangY.T., WangC.Y., TsaiI.J., WuK.D., HwangJ.J.High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease.Clin Infect Dis2006; 42: 66–72.
192.
GervasoniC., BergiaR., CozziV., ClementiE., CattaneoD.Is it time to revise linezolid doses in peritoneal dialysis patients? A case series.J Antimicrob Chemother2015; 70: 2918–20.
193.
GuayD.R., MeatherallR.C., BaxterH., JacykW.R., PennerB.Pharmacokinetics of metronidazole in patients undergoing continuous ambulatory peritoneal dialysis.Antimicrob Agents Chemother1984; 25: 306–10.
194.
SkaliotiC., TsaganosT., StamatiadisD., Giamarellos-BourboulisE.J., BoletisJ., KanellakopoulouK.Pharmacokinetics of moxifloxacin in patients undergoing continuous ambulatory peritoneal dialysis.Perit Dial Int2009; 29: 575–9.
195.
CelikA., CiritM., TüngerA., AkçiçekF., BasçiA.Treatment of CAPD peritonitis with oral trimethoprim/sulfamethoxazole and intraperitoneal aminoglycoside combination.Perit Dial Int1999; 19: 284–5.
196.
LoW.K., ChanC.Y., ChengS.W., PoonJ.F., ChanD.T., ChengI.K.A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis.Am J Kidney Dis1996; 28: 549–52.
197.
YapD.Y., ChoyC.B., MokM.M., WongT.K., ChanT.M.Burkholderia cepacia—an uncommon cause of exit-site infection in a peritoneal dialysis patient.Perit Dial Int2014; 34: 471–2.
TsaiS.F.Catheter related infection due to Mycobacterium abscessus in a patient under peritoneal dialysis.Ther Apher Dial2013; 17: 349–50.
200.
HirohamaD., IshibashiY., KawarazakiH., KumeH., FujitaT.Successful treatment of Mycobacterium gordonae exit-site and tunnel infection by partial catheter reimplantation of the Tenckhoff catheter.Perit Dial Int2011; 31: 368–70.
201.
CancariniG.C., ManiliL., BrunoriG., CameriniC., ZubaniR., ColombritaD.Simultaneous catheter replacement/removal during infectious complications in peritoneal dialysis.Adv Perit Dial1994; 10: 210–3.
202.
CrabtreeJ.H., SiddiqiR.A.Simultaneous catheter replacement for infectious and mechanical complications without interruption of peritoneal dialysis.Perit Dial Int2016; 36: 182–7.
203.
ScalamognaA., De VecchiA., MaccarioM., CastelnovoC., PonticelliC.Cuff-shaving procedure. A rescue treatment for exit-site infection unresponsive to medical therapy.Nephrol Dial Transplant1995; 10: 2325–7.
204.
SuhH., WadhwaN.K., CabraldaT., BonannoJ., WasilukA., SorrentoJ.Persistent exit-site/tunnel infection and subcutaneous cuff removal in PD patients.Adv Perit Dial1997; 13: 233–6.
AndreoliS.P., WestK.W., GrosfeldJ.L., BergsteinJ.M.A technique to eradicate tunnel infection without peritoneal dialysis catheter removal.Perit Dial Bull1984; 4: 156–7.
207.
TerawakiH., NakanoH., OguraM., KadomuraM., HosoyaT., NakayamaM.Unroofing surgery with en bloc resection of the skin and tissues around the peripheral cuff.Perit Dial Int2013; 33: 573–6.
ChaoS.H., TsaiT.J.Partial replantation of Tenckhoff catheters to treat intractable exit-site/tunnel infection.J Am Soc Nephrol1996; 7: 1085–7.
210.
WuY.M., TsaiM.K., ChaoS.H., TsaiT.J., ChangK.J., LeeP.H.Surgical management of refractory exit-site/tunnel infection of Tenckhoff catheter: technical innovations of partial replantation.Perit Dial Int1999; 19: 451–4.
211.
FukazawaM., MatsushitaK., TanabeN., MochizukiT., HaraT., TakedaM.A novel salvage technique that does not require catheter removal for exit-site infection.Perit Dial Int2002; 22: 618–21.
212.
MuraokaK., IshibashiY., YamaguchiJ., KawarazakiH., KumeH., FujitaT.Early partial re-implantation of Tenckhoff catheters to treat intractable exit-site or tunnel infection.Perit Dial Int2011; 31: 350–3.
213.
ChoK.H., DoJ.Y., ParkJ.W., YoonK.W.Catheter revision for the treatment of intractable exit site infection/tunnel infection in peritoneal dialysis patients: a single centre experience.Nephrology (Carlton)2012; 17: 760–6.
